The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 5, 2013, Pages 300-305

  Al Azzam, S I ^a   Alkhateeb, A M ^a   Al Azzeh, O ^a   Alzoubi, K H ^a   Khabour, O F ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

deiodinase type||; hypothyroid; Jordan; levothyroxine; polymorphism

Indexed keywords

DEIODINASE TYPE II; IODIDE PEROXIDASE; LEVOTHYROXINE; THYROTROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FREE THYROXINE INDEX; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION TEST; TREATMENT RESPONSE; WAIST CIRCUMFERENCE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; HYPOTHYROIDISM; IODIDE PEROXIDASE; JORDAN; MALE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROXINE;

EID: 84877832820     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1331695     Document Type: Article

References (37)

1. Todd C. H. Management of thyroid disorders in primary care: challenges and controversies. Postgrad Med J: 2009; 85 655 659
2. Vaidya B., Pearce S. H. Management of hypothyroidism in adults. BMJ: 2008; 337 a801
3. Baskin H. J., Cobin R. H., Duick D. S. et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract: 2002; 8 457 469
4. Checchi S., Montanaro A., Pasqui L. et al. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab: 2008; 93 465 469 (Pubitemid 351240817)
5. Jonklaas J. Gender and Age Differences in Levothyroxine Dose Requirement. Endocrine Practice: 2009; 15 1 23
6. Peeters R. P., van Toor H., Klootwijk W. et al. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab: 2003; 88 2880 2888 (Pubitemid 36724470)
7. Kim B. W., Bianco A. C. For some, L-thyroxine replacement might not be enough: a genetic rationale. J Clin Endocrinol Metab: 2009; 94 1521 1523
8. Torlontano M., Durante C., Torrente I. et al. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab: 2008; 93 910 913 (Pubitemid 351398572)
9. Guo T. W., Zhang F. C., Yang M. S. et al. Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J Med Genet: 2004; 41 585 590
10. Peeters R. P., van den Beld A. W., Attalki H. et al. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am J Physiol Endocrinol Metab: 2005; 289 E75 E81 (Pubitemid 40874937)
11. Heemstra K. A., Soeters M. R., Fliers E. et al. Type 2 iodothyronine deiodinase in skeletal muscle: effects of hypothyroidism and fasting. J Clin Endocrinol Metab: 2009; 94 2144 2150
12. Schneider M. J., Fiering S. N., Pallud S. E. et al. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol: 2001; 15 2137 2148 (Pubitemid 33141133)
13. Maia A. L., Kim B. W., Huang S. A. et al. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest: 2005; 115 2524 2533 (Pubitemid 41266215)
14. Panicker V., Saravanan P., Vaidya B. et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab: 2009; 94 1623 1629
15. He B., Li J., Wang G. et al. Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population. Prog Neuropsychopharmacol Biol Psychiatry: 2009; 33 986 990
16. Celi F. S., Canettieri G., Mentuccia D. et al. Structural organization and chromosomal localization of the human type II deiodinase gene. Eur J Endocrinol: 2000; 143 267 271 (Pubitemid 30622362)
17. Nair S., Muller Y. L., Ortega E. et al. Association Analyses of Variants in the DIO2 Gene with Early-Onset Type 2 Diabetes Mellitus in Pima Indians. Thyroid: 2012; 22 80 87
18. Gharibeh M. Y., Al Tawallbeh G. M., Abboud M. M. et al. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab: 2010; 36 443 449
19. Hueston W. J. Treatment of hypothyroidism. Am Fam Physician: 2001; 64 1717 1724 (Pubitemid 33095867)
20. Medline database [database on the Internet] 2010 [cited June 2010]. Available from www.ncbi.nlm.gov/SNP/
21. The human genome browser at UCSC Genome. [database on the Internet]. USCS Genome Bioinformatics [cited June 2010]. Available from: genome.uscs.edu
22. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., Misener S. (eds.). Bioinformatics Methods and Protocols: Methods in Molecular Biology [database on the Internet].: 2000; [cited 10/26/2009]. Available from: http://fokker.wi.mit.edu/primer3/
23. Vincze T., Posfai J., Roberts R. J. NEBcutter: A program to cleave DNA with restriction enzymes. Nucleic Acids Res: 2003; 31 3688 3691 (Pubitemid 37442224)
24. Maps sites for restriction enzymes, a.k.a. restriction endonucleases, in DNA sequences [database on the Internet] 2010 [cited July 2010]. Available from www.restrictionmapper.org
25. Heemstra K. A., Hoftijzer H. C., van der Deure W. M. et al. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf): 2009; 71 279 283
26. Mentuccia D., Proietti-Pannunzi L., Tanner K. et al. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes: 2002; 51 880 883 (Pubitemid 34760206)
27. Dora J. M., Machado W. E., Rheinheimer J. et al. Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. Eur J Endocrinol: 2010; 163 427 434
28. Rizk N., Amin M., Yousef M. A pilot study on metabolic syndrome and its associated features among Qatari schoolchildren. Int J Gen Med: 2011; 4 521 525
29. Fiorito M., Torrente I., De Cosmo S. et al. Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome. Obesity (Silver Spring): 2007; 15 2889 2895 (Pubitemid 351256647)
30. Medici M., van der Deure W. M., Verbiest M. et al. A large-scale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels. Eur J Endocrinol: 2011; 164 781 788
31. van der Deure W. M., Peeters R. P., Visser T. J. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol: 2010; 44 1 11
32. Rizos C. V., Elisaf M. S., Liberopoulos E. N. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J: 2011; 5 76 84
33. Ganie M. A., Laway B. A., Wani T. A. et al. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome. Fertil Steril: 2011; 95 2039 2043
34. Asvold B. O., Bjoro T., Vatten L. J. Association of serum TSH with high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab: 2009; 94 5023 5027
35. Alevizaki M., Saltiki K., Voidonikola P. et al. Free thyroxine is an independent predictor of subcutaneous fat in euthyroid individuals. Eur J Endocrinol: 2009; 161 459 465
36. Ruhla S., Weickert M. O., Arafat A. M. et al. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf): 2010; 72 696 701
37. Jordan in Numbers. [Internet]. Amman, Jordan, Department of statistics: 2007; Available from http://www.dos.gov.jo